Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Liou JP
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=5.076
------>paper_class3=2
------>paper_class2=1
------>vol=45
------>confirm_bywho=None
------>insert_bywho=jpl
------>Jurnal_Rank=8.3
------>authors4_c=
------>comm_author=
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=None
------>page2=2562
------>medlineContent=
------>unit=000
------>insert_date=20050404
------>iam=1
------>update_date=None
------>author=???
------>change_event=2
------>ISSN=
------>authors_c=
------>score=500
------>journal_name=J. Med. Chem.
------>paper_name=Synthesis and Structure-Activity Relationship of 2-Aminobenzophenone derivatives as antimitotic Agents.
------>confirm_date=None
------>tch_id=093131
------>pmid=12036364
------>page1=2556
------>fullAbstract=A new type of inhibitor of tubulin polymerization was discovered on the basis of the combretastatin molecular skeleton. The lead compounds in this series, compounds 6 and 7, strongly inhibited tubulin polymerization in vitro and significantly arrested cells at the G(2)/M phase. Compounds 6 and 7 yielded 50- to 100-fold lower IC(50) values than did combretastatin A-4 against Colo 205, NUGC3, and HA22T human cancer cell lines as well as similar or greater growth inhibitory activities than did combretastain A-4 against DLD-1, HR, MCF-7, DU145, HONE-1, and MES-SA/DX5 human cancer cell lines. Structure-activity relationship information revealed that introduction of an amino group at the ortho position of the benzophenone ring plays an integral role for increased growth inhibition.
------>tmu_sno=None
------>sno=10643
------>authors2=Chang CW
------>authors3=Song JS
------>authors4=Yeh CF
------>authors5=Hung HH
------>authors6=Liu SH, Hsieh HP
------>authors6_c=
------>authors=Liou JP
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=
------>publish_area=0
------>updateTitle=Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2002
------>submit_flag=None
------>publish_month=1
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z